SMMNY (SMMNY) Stock Price & Analysis
SMMNY (SMMNY) rose 0.18% to USD 22.59 as of September 8, 2026 at 11:01 UTC, according to Nexqual real-time market data.
SMMNY last closed at USD 22.55; the session ranged USD 22.56–22.72 on volume of 8,298 shares. Market capitalization is $50.57B, with a 52-week range of USD 19.2–28.92 (PNK). Source: Nexqual, September 8, 2026 at 11:01 UTC.
Key Statistics (as of September 8, 2026 at 11:01 UTC)
| Price | USD 22.59 |
|---|---|
| Change | ▲ 0.18% (up) |
| Previous Close | USD 22.55 |
| Open | USD 22.68 |
| Day Range | USD 22.56 – 22.72 |
| 52-Week Range | USD 19.2 – 28.92 |
| Volume | 8,298 shares |
| Market Cap | $50.57B |
| Exchange | PNK |
Technical Analysis (SMMNY)
Nexqual's technical model rates SMMNY "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 11:01 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 58.77 (neutral) |
| vs SMA50 | Above (USD 21.39) |
| MACD | 0.31 (positive) |
Analyst Ratings (SMMNY)
Wall Street analysts rate SMMNY "Buy" based on 2 analysts, with a mean price target of USD 24.35 (range USD 20.7–28), per Nexqual as of September 8, 2026 at 11:01 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 24.35 |
| High Target | USD 28 |
| Low Target | USD 20.7 |
| Buy / Hold / Sell | 2 / 1 / 0 |
Earnings (SMMNY)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.37 |
| Revenue Estimate | $6.74B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.4 vs est 0.29 ▲ beat |
| 2025-09-30 | USD 0.39 vs est 0.43 ▼ miss |
Source: Nexqual, September 8, 2026 at 11:01 UTC.
Financials & Fundamentals (SMMNY)
| Total Revenue | $23.17B |
|---|---|
| Revenue Growth (YoY) | +1.80% |
| Gross Margin | +39.02% |
| Operating Margin | +16.41% |
| Profit Margin | +9.55% |
| ROE | +12.15% |
| Debt / Equity | 78.3 |
| Current Ratio | 1.16 |
| Total Cash | $2.36B |
| Total Debt | $15.00B |
| Free Cash Flow | $2.15B |
Source: Nexqual, September 8, 2026 at 11:01 UTC.
Financial Health Score (SMMNY)
Nexqual rates SMMNY's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 11:01 UTC.
| Growth | Mixed — Revenue +4.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 39%, operating 16% |
| Balance Sheet | Mixed — $2.36B cash vs $15.0B debt |
| Cash Flow | Solid — FCF $2.15B, 9% margin |
| Efficiency | Mixed — ROE 12%, ROA 4.5% |
Ownership (SMMNY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.24B |
| Float | 715.43M |
Source: Nexqual, September 8, 2026 at 11:01 UTC.
Leadership (SMMNY)
SMMNY is led by Bernhard Montag (age 56), President, CEO & Chairman of Management Board, per Nexqual as of September 8, 2026 at 11:01 UTC.
| President, CEO & Chairman of Management Board | Bernhard Montag (age 56) |
|---|---|
| CFO & Member of Management Board | Jochen Schmitz (age 59) |
| Chief Human Resources Officer, Labor Director & Member of Management Board | Darleen Caron (age 61) |
| Executive Vice President of Finance | Christian Klaussner |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MKKGY | Merck KGaA | USD 31.51 | ▼ 2.69% |
| CSLLY | CSL Ltd. | USD 31.61 | ▲ 0.99% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 21.59 | ▲ 0.09% |
| SEMHF | SIEMENS HEALTHINEERS AG | USD 45.23 | ▼ 2.62% |
| HOCPY | Hoya Corp. | USD 156.1 | ▲ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 11:01 UTC. This page is informational and not investment advice.